This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dong, Q. Articles by Spiegel, A. M. Search for Related Content PubMed PubMed Citation Articles by Dong, Q. Articles by Spiegel, A. M.

Loss of Heterozygosity at 11q13: Analysis of Pituitary Tumors, Lung Carcinoids, Lipomas, and Other Uncommon Tumors in Subjects with Familial Multiple Endocrine Neoplasia Type 1

Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases (Q.D., M.S., S.J.M., A.M.S.); the Laboratory of Pathology, National Cancer Institute (L.V.D., M.R.E., Z.Z., I.A.L., L.A.L.); and the Laboratory of Gene Transfer, National Institute Human Genome Research (S.C.C., S.C.G., P.M., F.S.C.), National Institutes of Health, Bethesda, Maryland 20892

Address all correspondence and requests for reprints to: Dr. Allen M. Spiegel, Building 10, Room 9N-222, National Institutes of Health, Bethesda, Maryland 20892. E-mail: allens{at}amb.niddk.nih.gov

Loss of heterozygosity (LOH) for polymorphic markers flanking the multiple endocrine neoplasia type 1 (MEN-1) gene in parathyroid and pancreatic islet tumors from subjects with familial MEN-1 (FMEN-1) has been well documented and has led to the hypothesis that the MEN-1 gene functions as a tumor suppressor. To assess the role of the MEN-1 gene in the pathogenesis of tumors less commonly associated with MEN-1, we employed a large number of highly informative polymorphic markers closely linked to the MEN-1 gene to study a series of 13 such tumors from subjects with FMEN-1 for LOH at 11q13. We were able to identify LOH for 1 or more 11q13 markers in 2 of 3 pituitary tumors, 3 lung carcinoids, and 1 of 2 lipomas. In every case studied, the allele lost represented the normal allele inherited from the unaffected parent. No LOH was detected in 3 skin angiofibromas, an esophageal leiomyoma, or a renal angiomyolipoma despite the presence of at least 2 informative markers for each tumor. Our results suggest that, like that for parathyroid and pancreatic islet tumors, the pathogenesis of pituitary tumors, lung carcinoids, and lipomas occurring in subjects with FMEN-1 probably involves loss of the normal tumor suppressor function of the MEN-1 gene. Our inability to detect 11q13 LOH in skin angiofibromas, leiomyoma, and angiomyolipoma from subjects with FMEN-1 is consistent with the possibility that these neoplasms arose independently by a mechanism unrelated to the MEN-1 gene, but a role for the MEN-1 gene in the pathogenesis of these tumors cannot be definitively excluded until the gene itself is identified and evaluated for small intragenic deletions or point mutations in such tumors.

This article has been cited by other articles:

				M Anlauf, A Perren, T Henopp, T Rudolf, N Garbrecht, A Schmitt, A Raffel, O Gimm, E Weihe, W T Knoefel, et al. Allelic deletion of the MEN1 gene in duodenal gastrin and somatostatin cell neoplasms and their precursor lesions Gut, May 1, 2007; 56(5): 637 - 644. [Abstract] [Full Text] [PDF]

				N. S. Pellegata, L. Quintanilla-Martinez, H. Siggelkow, E. Samson, K. Bink, H. Hofler, F. Fend, J. Graw, and M. J. Atkinson Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans PNAS, October 17, 2006; 103(42): 15558 - 15563. [Abstract] [Full Text] [PDF]

				J. M. Zuetenhorst and B. G. Taal Metastatic Carcinoid Tumors: A Clinical Review Oncologist, February 1, 2005; 10(2): 123 - 131. [Abstract] [Full Text] [PDF]

				B. Asgharian, M. L. Turner, F. Gibril, L. K. Entsuah, J. Serrano, and R. T. Jensen Cutaneous Tumors in Patients with Multiple Endocrine Neoplasm Type 1 (MEN1) and Gastrinomas: Prospective Study of Frequency and Development of Criteria with High Sensitivity and Specificity for MEN1 J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5328 - 5336. [Abstract] [Full Text] [PDF]

				B. Asgharian, Y.-J. Chen, N. J. Patronas, P. L. Peghini, J. C. Reynolds, A. Vortmeyer, Z. Zhuang, D. J. Venzon, F. Gibril, and R. T. Jensen Meningiomas May Be a Component Tumor of Multiple Endocrine Neoplasia Type 1 Clin. Cancer Res., February 1, 2004; 10(3): 869 - 880. [Abstract] [Full Text] [PDF]

				F Sandrini, L S Kirschner, T Bei, C Farmakidis, J Yasufuku-Takano, K Takano, T R Prezant, S J Marx, W E Farrell, R N Clayton, et al. PRKAR1A, one of the Carney complex genes, and its locus (17q22-24) are rarely altered in pituitary tumours outside the Carney complex J. Med. Genet., December 1, 2002; 39(12): e78 - 78. [Full Text] [PDF]

				J. L. McKeeby, X. Li, Z. Zhuang, A. O. Vortmeyer, S. Huang, M. Pirner, M. C. Skarulis, L. James-Newton, S. J. Marx, and I. A. Lubensky Multiple Leiomyomas of the Esophagus, Lung, and Uterus in Multiple Endocrine Neoplasia Type 1 Am. J. Pathol., September 1, 2001; 159(3): 1121 - 1127. [Abstract] [Full Text] [PDF]

				D. Desai, L. A. McPherson, J. P. T. Higgins, and R. J. Weigel Genetic Analysis of a Papillary Thyroid Carcinoma in a Patient with MEN1 Ann. Surg. Oncol., May 1, 2001; 8(4): 342 - 346. [Abstract] [Full Text] [PDF]

				J. Zhao, R. R. de Krijger, D. Meier, E.-J. M. Speel, P. Saremaslani, S. Muletta-Feurer, C. Matter, J. Roth, P. U. Heitz, and P. Komminoth Genomic Alterations in Well-Differentiated Gastrointestinal and Bronchial Neuroendocrine Tumors (Carcinoids) : Marked Differences Indicating Diversity in Molecular Pathogenesis Am. J. Pathol., November 1, 2000; 157(5): 1431 - 1438. [Abstract] [Full Text] [PDF]

				A. K. Walch, H. F. Zitzelsberger, M. M. Aubele, A. E. Mattis, M. Bauchinger, S. Candidus, H. W. Prauer, M. Werner, and H. Hofler Typical and Atypical Carcinoid Tumors of the Lung Are Characterized by 11q Deletions as Detected by Comparative Genomic Hybridization Am. J. Pathol., October 1, 1998; 153(4): 1089 - 1098. [Abstract] [Full Text] [PDF]

				S. L. Asa, K. Somers, and S. Ezzat The MEN-1 Gene Is Rarely Down-Regulated in Pituitary Adenomas J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3210 - 3212. [Abstract] [Full Text]

				C. Tanaka, T. Kimura, P. Yang, M. Moritani, T. Yamaoka, S. Yamada, T. Sano, K. Yoshimoto, and M. Itakura Analysis of Loss of Heterozygosity on Chromosome 11 and Infrequent Inactivation of the MEN1 Gene in Sporadic Pituitary Adenomas J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2631 - 2634. [Abstract] [Full Text]

				C. A. Stratakis, L. S. Kirschner, S. E. Taymans, I. P. M. Tomlinson, D. J. Marsh, D. J. Torpy, C. Giatzakis, D. M. Eccles, J. Theaker, R. S. Houlston, et al. Carney Complex, Peutz-Jeghers Syndrome, Cowden Disease, and Bannayan-Zonana Syndrome Share Cutaneous and Endocrine Manifestations, But Not Genetic Loci J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2972 - 2976. [Abstract] [Full Text]

				S. C. Guru, S. K. Agarwal, P. Manickam, S.-E. Olufemi, J. S. Crabtree, J. M. Weisemann, M. B. Kester, Y. S. Kim, Y. Wang, M. R. Emmert-Buck, et al. A Transcript Map for the 2.8-Mb Region Containing the Multiple Endocrine Neoplasia Type 1 Locus Genome Res., July 1, 1997; 7(7): 725 - 735. [Abstract] [Full Text] [PDF]